23 June 2022
- 13:0613:06, 23 June 2022 diff hist 0 N File:Image8-ebafa5124d8196802324f40aa657b1d6.png No edit summary current
- 13:0613:06, 23 June 2022 diff hist 0 N File:Image7-5c82f9d4103405c86b2901b357f8d53e.png No edit summary current
- 13:0613:06, 23 June 2022 diff hist 0 N File:Image6-c6dd0fbb760921c68274a02aac6607ec.png No edit summary current
- 13:0613:06, 23 June 2022 diff hist 0 N File:Image5-e82b789cadf89720d0020af2ea338683.png No edit summary current
- 13:0613:06, 23 June 2022 diff hist 0 N File:Image4-666e5cc13984687522afaf3577c161a8.png No edit summary current
- 13:0513:05, 23 June 2022 diff hist 0 N File:Image3-9589bf31951e17ab949784badc9e0c4c.png No edit summary current
- 13:0513:05, 23 June 2022 diff hist +458 EQS Group →Summary Tag: Visual edit
- 12:5712:57, 23 June 2022 diff hist +35 EQS Group No edit summary
- 12:5512:55, 23 June 2022 diff hist 0 N File:EQS Group logo.jpg No edit summary current
- 12:5512:55, 23 June 2022 diff hist +16 EQS Group →Management team
- 12:5412:54, 23 June 2022 diff hist +1,523 EQS Group No edit summary Tag: Visual edit
- 01:1401:14, 23 June 2022 diff hist +40,644 N EQS Group Created page with "EQS is in a strong position to build its client base as the EU whistleblowing directive comes into force across Europe. Delays in adoption of formal legislation are a frustration but do not detract from the strength of the underlying proposition. EQS retains its ambition to be the leading European cloud provider for global investor relations and corporate compliance solutions by 2025. The €45m raised in March will help fund the repayment of short-term bank and vendor l..." Tag: Visual edit
22 June 2022
- 21:5621:56, 22 June 2022 diff hist +64 Scandion Oncology →Drug-resistance mechanisms are commonly reported Tag: Visual edit
- 16:2116:21, 22 June 2022 diff hist +87 Scandion Oncology No edit summary
- 16:1916:19, 22 June 2022 diff hist 0 N File:Scandion Oncology.jpeg No edit summary current
- 16:1716:17, 22 June 2022 diff hist +39 Scandion Oncology No edit summary
- 16:1416:14, 22 June 2022 diff hist +204 Scandion Oncology →Two shots on goal for SCO-101 Tag: Visual edit
- 16:1016:10, 22 June 2022 diff hist +104 Scandion Oncology →Further studies will require fresh capital Tag: Visual edit
- 16:0616:06, 22 June 2022 diff hist 0 N File:Image3-f037ec1ee2495554a573c0cdde896311.png No edit summary current
- 16:0616:06, 22 June 2022 diff hist 0 N File:Image4-6ff227f569067ae2b29573f4aa4f3314.png No edit summary current